A Randomized Double-Blind Placebo-Controlled Trial to Evaluate Prophylactic Effect of Traditional Chinese Medicine Supplementing Qi and Hemostasis Formula on Gastrointestinal Bleeding after Percutaneous Coronary Intervention in Patients at High Risks

Table 4

Comparison between patients with and without ischemic events occurrence.

	Ischemic cardiac event occurred (N=8)	Ischemic cardiac event absent (N=109)	Statistics	P value
Age			-1.11(Z)	0.2655
Gender			-(Fisher)	0.0245
Male N(%)	6(75.00)	36(33.03)
Female N(%)	2(25.00)	73(66.97)
Weight (kg)			-0.40(Z)	0.6889
Height (m)			0.65(Z)	0.5158
SBP (mmHg)			1.29(Z)	0.1967
HR (beat/min)			1.00(Z)	0.3175
Smoking	2(25.00)	38(34.86)	-(Fisher)	0.7137
Alcohol intake	1(12.50)	23(21.10)	-(Fisher)	1.0000
Duration of smoking			-1.27(Z)	0.2044
CRUSADE score			1.70(Z)	0.0896
Admitting condition			-(Fisher)	1.0000
Urgent N(%)	4(50.00)	55(50.46)
Selective N(%)	4(50.00)	54(49.54)
Admitting diagnosis				0.7641
STEMI N(%)	2(25.00)	24(22.02)
NSTEMI N(%)	3(37.50)	25(22.94)
UAP N(%)	2(25.00)	39(35.78)
SAP N(%)	1(12.50)	21(19.27)
Medical history
Hypertension N(%)	7(87.50)	80(73.39)	-(Fisher)	0.6779
Type-2 DM N(%)	6(75.00)	59(54.13)	-(Fisher)	0.2971
Lipid disorder N(%)	2(25.00)	26(23.85)	-(Fisher)	1.0000
Chronic heart dysfunction N(%)	2(25.00)	26(23.85)	-(Fisher)	1.0000
Chronic kidney dysfunction N(%)	4(50.00)	27(24.77)	-(Fisher)	0.2056
Chronic bronchitis N(%)	1(12.50)	8(7.34)	-(Fisher)	0.4838
Anemia N(%)	0(0.00)	4(3.67)	-(Fisher)	1.0000
Prior cerebrovascular disease N(%)	1(12.50)	38(34.86)	-(Fisher)	0.2659
Prior peptic ulcer N(%)	1(12.50)	7(6.42)	-(Fisher)	0.4429
PCI access site			-(Fisher)	0.7330
Radial artery N(%)	5(62.50)	76(69.72)
Femoral artery N(%)	3(37.50)	31(28.44)
Both N(%)	0(0.00)	2(1.83)
Number of diseased vessel			0.39(Z)	0.6975
Single N(%)	3(37.50)	30(27.52)
Double N(%)	0(0.00)	31(28.44)
Multiple N(%)	5(62.50)	48(44.04)
Part of diseased vessel
LM N(%)	3(37.50)	15(13.76)	-(Fisher)	0.1046
AD N(%)	6(75.00)	88(80.73)	-(Fisher)	0.6548
CX N(%)	5(62.50)	63(57.80)	-(Fisher)	1.0000
RC N(%)	7(87.50)	68(62.39)	-(Fisher)	0.2557
Others N(%)	1(12.50)	16(14.68)	-(Fisher)	1.0000
IABP implantation	4(50.00)	29(26.61)	-(Fisher)	0.2191
Temporary cardiac pacemaker implantation	1(12.50)	6(5.50)	-(Fisher)	0.3992
Number of stent implantation			0.28(Z)	0.7830
TEG
			2.09(Z)	0.0366
Inhibition of ADP			-2.45(Z)	0.0144
Inhibition of AA			1.17(Z)	0.2413